The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence.


Journal

AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133

Informations de publication

Date de publication:
Dec 2021
Historique:
accepted: 23 04 2021
pubmed: 4 5 2021
medline: 23 11 2021
entrez: 3 5 2021
Statut: ppublish

Résumé

We analyzed data from 1428 users of the dapivirine vaginal ring, who participated in the MTN-020/ASPIRE phase III trial and subsequent open-label extension MTN-025/HOPE trial, to examine relationships between perceived ring protection, social disclosures, and self-reported ring adherence. In HOPE, 77% perceived the ring to be highly effective, and this view was associated with speaking: (a) to a greater number of people about the study, (b) with other participants, (c) to more people who were in favor of the ring, and (d) to more people whose opinions were valued. Reported adherence was not directly associated with perceived protection but was associated with disclosing to someone who was in favor of the ring. These findings suggest the importance of women's internalized ideas about the protective benefits of the DVR in sharing information about the ring and the importance of social support on adherence.

Identifiants

pubmed: 33939034
doi: 10.1007/s10461-021-03286-w
pii: 10.1007/s10461-021-03286-w
pmc: PMC8563504
mid: NIHMS1740628
doi:

Substances chimiques

Anti-HIV Agents 0
Pyrimidines 0
Dapivirine TCN4MG2VXS

Types de publication

Clinical Trial, Phase III Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4169-4179

Subventions

Organisme : NIAID NIH HHS
ID : UM1 AI069423
Pays : United States
Organisme : NIH HHS
ID : UM1AI106707
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068633
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068615
Pays : United States
Organisme : NIH HHS
ID : UM1AI068633
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI106707
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069518
Pays : United States
Organisme : NIH HHS
ID : UM1AI068615
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069436
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069436
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069469
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069530
Pays : United States

Investigateurs

Jared Baeten (J)
Thesla Palanee-Phillips (T)
Nyaradzo Mgodi (N)
Elizabeth Brown (E)
Lydia Soto-Torres (L)
Katie Schwartz (K)
Ashley Mayo (A)
Bonus Makanani (B)
Francis Martinson (F)
Lameck Chinula (L)
Linda-Gail Bekker (LG)
Gonasagrie Nair (G)
Vaneshree Govender (V)
Samantha Siva (S)
Zakir Gaffoor (Z)
Logashvari Naidoo (L)
Arendevi Pather (A)
Nitesha Jeenarain (N)
Gita Ramjee (G)
Dishiki Kalonji (D)
Nishanta Singh (N)
Leila Mansoor (L)
Flavia Matovu (F)
Brenda Gati (B)
Portia Hunidzarira (P)
Felix Mhlanga (F)

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

N Engl J Med. 2015 Feb 5;372(6):509-18
pubmed: 25651245
AIDS Behav. 2019 Jul;23(7):1917-1924
pubmed: 30600456
J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):394-403
pubmed: 30633040
N Engl J Med. 2016 Dec;375(22):2121-2132
pubmed: 26900902
AIDS Patient Care STDS. 2013 Apr;27(4):248-54
pubmed: 23565928
J Acquir Immune Defic Syndr. 2018 Dec 15;79(5):580-589
pubmed: 30239426
AIDS Behav. 2016 Nov;20(11):2700-2708
pubmed: 27098408
AIDS Behav. 2019 Feb;23(2):504-512
pubmed: 30218318
N Engl J Med. 2012 Aug 2;367(5):399-410
pubmed: 22784037
AIDS Behav. 2020 May;24(5):1443-1451
pubmed: 31696371
AIDS Behav. 2020 May;24(5):1432-1442
pubmed: 31667678
AIDS Behav. 2020 Aug;24(8):2387-2399
pubmed: 31980993
AIDS. 2017 May 15;31(8):1159-1167
pubmed: 28441175
J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):46-53
pubmed: 29847480
N Engl J Med. 2012 Aug 2;367(5):411-22
pubmed: 22784040
AIDS Behav. 2018 Apr;22(4):1063-1074
pubmed: 28176168
J Int AIDS Soc. 2016 Feb 04;19(1):20642
pubmed: 26850270
AIDS Behav. 2016 Nov;20(11):2654-2661
pubmed: 26906023
N Engl J Med. 2016 Dec;375(22):2133-2143
pubmed: 27959766
J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S122-9
pubmed: 23764623
BMJ Open. 2014 Nov 20;4(11):e005717
pubmed: 25412863
AIDS Behav. 2017 May;21(5):1325-1335
pubmed: 27900502
J Int AIDS Soc. 2020 Nov;23(11):e25634
pubmed: 33206462
J Int AIDS Soc. 2020 Jun;23(6):e25536
pubmed: 32524700
PLoS Med. 2014 Mar 04;11(3):e1001613
pubmed: 24595035
AIDS Care. 2013 Aug;25(8):961-7
pubmed: 23252473
J Int AIDS Soc. 2016 Oct 18;19(7(Suppl 6)):21120
pubmed: 27760689

Auteurs

Marie C D Stoner (MCD)

Women's Global Health Imperative, RTI International, 2150 Shattuck avenue, Berkeley, CA, USA. mcstoner@rti.org.

Elizabeth R Brown (ER)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Department of Biostatistics, University of Washington, Seattle, WA, USA.

Thesla Palanee-Phillips (T)

Wits Reproductive Health and HIV Institute, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa.

Leila E Mansoor (LE)

Center for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.

Tchangani Tembo (T)

University of North Carolina Project Malawi, Lilongwe, Malawi.

Gonasagrie Nair (G)

Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.

Carolyne Akello (C)

Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda.

Linly Seyama (L)

Malawi College of Medicine-John Hopkins University Research Project, Blantyre, Malawi.

Nitesha Jeenarain (N)

South African Medical Research Council, Durban, South Africa.

Logashvari Naidoo (L)

South African Medical Research Council, Durban, South Africa.

Nyaradzo Mgodi (N)

University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.

Portia Hunidzarira (P)

University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.

Miria Chitukuta (M)

University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.

Ariane van der Straten (A)

Women's Global Health Imperative, RTI International, 2150 Shattuck avenue, Berkeley, CA, USA.
Center for AIDS Prevention Studies, University of California San Francisco, San Francisco, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH